| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Rufinamide | Rufinamide Acid Impurity | VL3000005 | View CAS 166196-11-8 |
| Rufinamide | Rufinamide Impurity 1 | VL3000003 | View CAS 80819-65-4 |
| Rufinamide | Rufinamide Impurity 2 | VL3000004 | View |
| Rufinamide | Rufinamide Impurity 6 | VL3000001 | View |
| Rufinamide | Rufinamide Nitrile Impurity | VL3000006 | View CAS 202003-06-3 |
| Rufinamide | Rufinamide Related Compound B | VL3000002 | View CAS 217448-86-7 |
| Catalogue No. | VL3000005 |
| CAS No. | 166196-11-8 |
| Molecular Formula | C10H7F2N3O2 |
| Molecular Weight | 239.18 |
| Parent drug | Rufinamide |
| IUPAC Name | 1-(2, 6-difluorobenzyl)-1H-1, 2, 3-triazole-4-carboxylic acid |
| Synonyms | N/A |
| References | “Sci-Hub, Rufinamide for Generalized Seizures Associated with Lennox-Gastaut Syndrome, 10.1212/01.Wnl.0000303813.95800.0d.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1212/01.wnl.0000303813.95800.0d. |
| Status | In-stock |
| ListName | Rufinamide Acid Impurity |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
